Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1,214 Less Arrow 218 More Arrow 356
Earnings before taxes -6,975 Less Arrow -9,878 Less Arrow -11,965
EBITDA -5,818 Less Arrow -9,901 Less Arrow -13,116
Total assets 12,268 Less Arrow 7,847 More Arrow 19,641
Current assets 7,288 Less Arrow 2,608 More Arrow 14,456
Current liabilities 5,396 Less Arrow 1,133 More Arrow 3,371
Equity capital 6,873 Less Arrow 6,699 More Arrow 16,252
- share capital 8,461 Less Arrow 3,143 Less Arrow 3,134
Employees (average) 11 More Arrow 23 Less Arrow 22

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 56.0% More Arrow 85.4% Less Arrow 82.7%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -47.0% Less Arrow -123.1% More Arrow -59.1%
Current ratio 135.1% More Arrow 230.2% More Arrow 428.8%
Return on equity (ROE) -101.5% Less Arrow -147.5% More Arrow -73.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -12 More Arrow 1 More Arrow 2
Chg. No. of employees % -52% More Arrow 5% More Arrow 10%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.